Finance

Lists
HYPE3:BVMF
Hypera SA
25,78 BRL
0,00%
(0,00) 1D
14-окт., 17:06:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for HYPE3...
Open
25,66 BRL
High
25,89 BRL
Low
25,18 BRL
Mkt. cap
18,15 млд
Avg. vol.
4,05 млн
Volume
5,17 млн
Dividend
3,72%
Quarterly dividend
0,24 BRL
Ex-dividend date
2026-ж., 9-фев.
P/E ratio
9,71
52-wk high
30,00 BRL
52-wk low
19,43 BRL
EPS
2,66 BRL
Shares outstanding
704,01 млн
No. of employees
11 миң
Open
25,66 BRL
High
25,89 BRL
Low
25,18 BRL
Mkt. cap
18,15 млд
Avg. vol.
4,05 млн
Volume
5,17 млн
Dividend
3,72%
Quarterly dividend
0,24 BRL
Ex-dividend date
2026-ж., 9-фев.
P/E ratio
9,71
52-wk high
30,00 BRL
52-wk low
19,43 BRL
EPS
2,66 BRL
Shares outstanding
704,01 млн
No. of employees
11 миң
News stories
From web sources and news partners
Profile
Hypera Pharma is a Brazilian multinational pharmaceutical company and is the largest Brazilian pharmaceutical company by market capitalization. Headquartered in São Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products. Wikipedia
About Hypera SA
CEO-
Employees10,6 миң
Founded2001
HeadquartersItaim Bibi, Сан-Па́улу штаты, Бразилия
SectorPharmaceutical industry
Next call 13 күндөн кийин
28-окт., шарш., 14:00
Fiscal period
Q3 2026
- / 0,73 BRL
Revenue / Est. (BRL)
- / 2,43 млд
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
2,23 млд
2,24 млд
2,02 млд
2,34 млд
Cost of goods sold
865,21 млн
858,94 млн
807,22 млн
892,99 млн
Cost of revenue
865,21 млн
858,94 млн
807,22 млн
892,99 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
687,46 млн
728,46 млн
703,28 млн
780,69 млн
Operating expense
688,45 млн
728,74 млн
701,06 млн
773,84 млн
Total operating expenses
1,55 млд
1,59 млд
1,51 млд
1,67 млд
Operating income
673,59 млн
649,38 млн
509,50 млн
669,87 млн
Other non operating income
-14,67 млн
-27,28 млн
-8,73 млн
-30,17 млн
EBT including unusual items
448,11 млн
439,21 млн
276,14 млн
492,29 млн
EBT excluding unusual items
452,42 млн
438,30 млн
279,75 млн
488,66 млн
Income tax expense
-5,77 млн
-10,46 млн
-69,54 млн
2,28 млн
Effective tax rate
-1,29%
-2,38%
-25,18%
0,46%
Other operating expenses
987,00 миң
283,00 миң
-2,21 млн
-6,84 млн
Net income
457,64 млн
450,99 млн
347,38 млн
490,24 млн
Net profit margin
20,55%
20,16%
17,22%
20,98%
Earnings per share
0,72
0,71
0,55
0,70
Interest and investment income
69,23 млн
68,87 млн
64,66 млн
63,02 млн
Interest expense
-283,65 млн
-268,84 млн
-282,34 млн
-209,57 млн
Net interest expenses
-214,42 млн
-199,97 млн
-217,68 млн
-146,55 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
728,99 млн
702,34 млн
562,68 млн
755,79 млн
Gain or loss from assets sale
-11,00 миң
-253,00 миң
-3,20 млн
-698,00 миң
AI content may include mistakes. Learn more
Google колдонмолору